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etary trends among racial and socioeconomic groups in
the United States between 1965 and 1989–1991. Judged
on the basis of today’s dietary wisdom, persons with high
incomes in 1965 had especially poor diets, with improve-
ment by 1989–1991. Persons with low incomes had less
change in diet over this period.
Dietary advice to the public, of course, has changed




 Emphasis on the four bas-
ic food groups (encouraging substantial intake of red meat
and whole milk) gradually shifted to an increasing concern
about saturated-fat intake. The authors’ data might largely
reflect greater access to evolving nutritional recommenda-
tions among those with high incomes and more disposable
income to spend at the grocery store to follow changing
dietary advice.
Do the authors have data comparing how well persons
in high- and low-income brackets in 1965 complied with
the diet recommendations then being offered to the pub-
lic? Perhaps persons with high incomes were more compli-
ant in following the best diet at the time, and what changed












New Orleans Veterans Affairs Medical Center




Popkin BM, Siega-Riz AM, Haines PS. A comparison of dietary trends 





The normal adult diet. In: Burton BT, ed. The Heinz handbook of nu-




Recommended allowances. In: Brock JF. Recent advances in human nu-




Recommended dietary allowances and the adequate diet. In: Krause 
MV, Mahan LK. Food, nutrition, and diet therapy: a textbook of nutrition-




Optimal nutrition for health and well-being. In: Burtis G, Davis J, Mar-





 Popkin and his colleagues conclude that
“by the 1989–1991 survey, the diets of all [socioeconomic
and racial] groups had improved and were relatively simi-
lar.” Although this may be true, the conclusion depends
on the respondents’ own recall of their diets over a one-
day period — a method that is notoriously prone to error.
In general, participants in dietary-recall studies tend to un-
derestimate the number of calories they consume and over-
estimate their nutrient intake.
An alternative explanation for the reported similarities
in diet may be that during the 25-year period between
1965 and 1989–1991 the respondents had been exposed
to enough information about what constitutes a good diet
to be able to report what they thought the investigators
wanted to hear. Thus, these results may measure the suc-
cess of educational efforts rather than any concomitant
change in actual eating behavior. The epidemic of obesity
in the United States, which is most severe among poorer,
nonwhite groups, suggests that some of our nutritional
habits have not improved. Figures about the kinds of food
that were actually purchased and consumed during the
study period are needed.
In 1973, Rathje and Murphy started the Garbage Proj-




 in an attempt to apply
state-of-the-art archeological techniques to the study of
contemporary urban garbage. By 1992 the project had an-
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amounts of food remnants and food packaging. The com-
position of this garbage was so at odds with what people
said they were eating that Rathje and Murphy coined the
term “lean cuisine syndrome.” They wrote:
People consistently underreport the amount of regular
soda, pastries, chocolate, and fats that they consume;
they consistently overreport the amount of fruits and
diet soda. . . . In sum, the data generated by the Gar-
bage Project in its cross-check of the USDA’s [U.S. De-
partment of Agriculture’s] Nationwide Food Consump-
tion Survey reveal that much of the information in the
government’s vaults about food consumption and waste




























 has set out the
two nutritional dilemmas. The first concerns well-circum-
stanced people, whose diet according to current guidelines
should revert “in many respects [to] the traditional eating
pattern of poor people throughout the world.” Then there
is the converse situation, “as people raise their standard of
living, they may adopt eating patterns that have tradition-
ally been associated with higher incomes but that are no
longer considered desirable.”
Among the white population of South Africa, causes of





 Among rural South African blacks living tra-
ditionally, there was until recently a high rate of mortality
among the very young, but among adults there was little
or no increase in weight or blood pressure with age. More-
over, diabetes, coronary heart disease, and diet-related can-
cers (colon, prostate, and breast) were either absent or
rare. There were certainly plenty of old people of 70 to 90
years of age, and some claimed to be 100. In strong con-
trast, nowadays, in big cities, where nearly half the black
population lives, there has been an enormous fall in child
mortality, resulting in a major increase in survival. Howev-
er, unfortunately, with the changes in diet and other as-
pects of lifestyle, the prevalences of dental caries, hyperten-
sion, obesity in women, and diabetes have risen and now
exceed those in whites.
The white population has virtually no intention of con-
forming to a “prudent” lifestyle, dietarily or otherwise.
Yet, ironically in recent years, the mortality rate from cor-




 The urban black
population, with its increase in socioeconomic status, is
determined to emulate the lifestyle of the whites, with ris-
ing intakes of energy and fat and falling intakes of fiber-
containing foods.
Kumanyika affirms that “as we learn more about diet-
related risks to health, we should not forget to use this
knowledge to guide public policy.” However, according to
Popkin et al., in the last generation, despite strong encour-
agement, the intake of energy from fat among those of
medium socioeconomic status has fallen only slightly, and
the number of servings of fruit and vegetables consumed
has remained virtually unchanged. As is the case regarding
the control of cancer, the knowledge is there but not the




How much does it matter? Although life span in devel-
oped and developing urban populations is at its highest
point ever, little improvement is likely to occur in the
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 Nusbaum and Eshleman suggest that die-
tary trends may reflect respondents’ adherence to the die-
tary guidelines of the time. From 1916 to 1976, nutrition-





 The basic five food groups of 1916 were re-
duced to the basic four (two daily servings of milk and of
meat, poultry, or eggs and four daily servings of fruits and
vegetables and of breads and grains) in the 1960s. Not un-
til the introduction of the U.S. Dietary Goals in 1977 did
dietary guidelines explicitly recommend nutrient limita-
tions for fats, sugars, and cholesterol. Neither our group
nor others have attempted to quantify the dietary guide-
lines of the 1960s or to ascertain who followed the guide-
lines most closely.
Eshleman is correct that obesity increased significantly
during the period we studied and that methods of collect-
ing dietary-intake data underestimate total intake for indi-
vidual subjects. Experiments using doubly labeled water to
measure energy expenditure versus intake measured by al-
ternative dietary-assessment methods concluded that peo-





 These experiments suggested that
most methods and people underestimated intake, but un-
derreporting was more common among those who were
or had been obese.
The many comparisons of the relative validity of dietary-
assessment methods concludes that although the use of a
single 24-hour period of recall is not an appropriate tool
for assessing a person’s usual diet, the method is quite ac-





 With regard to the use of these data to analyze trends,
there is little evidence of a systematic increase in the rate
of underestimation of food consumption over time, since
the methods used in the U.S. Department of Agriculture




We agree with Walker — knowledge alone is inadequate
without systematic programs and policies and a major shift
in public will. He is correct about the shifts in nutritional










crease in obesity and other factors linked with insulin re-
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 Walker’s comments are too pessimistic. He
implies that a decent standard of living is inevitably char-
acterized by an unhealthy lifestyle and that policy initia-
tives will not work. Should we then not attempt preven-
tion among black South Africans who, like U.S. blacks in
1965, may still eat the way we consider prudent? Having
a long way to go does not mean that we have made no
progress, but that progress is not fast enough. The poten-
tial for achieving lifestyle changes and improving wellness




Walker’s suggestion that dietary changes are unnecessary
because gains are being made anyway seems ill advised if,
in South Africa as in the United States, gains are driven by
treatment rather than prevention. Relying on treatment
while leaving detrimental lifestyles unchallenged is neither
feasible nor acceptable; it makes us a population of pa-
tients. Chronic-disease–related disabilities are costly and





 Moreover, if the U.S. experience is any indication,
it is unrealistic to assume that factors responsible for im-
proved health in white South Africans will necessarily ap-
ply to black South Africans. As Walker himself notes, once
chronic diseases become present in groups of blacks, their
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Enoxaparin as Prophylaxis against 




 We are concerned about the report of




 and the implications it may
have for patient care. They reported that among patients
who had total hip arthroplasty, the rate of venography-
confirmed deep-vein thrombosis was substantially reduced
in those who had continuing prophylaxis with the low-
molecular-weight heparin enoxaparin after hospital dis-
charge, compared with a control group that received enox-
aparin prophylaxis only while hospitalized. Although we
do not question the validity of these findings, we do chal-
lenge the clinical significance of the results. Venography-
confirmed deep-vein thrombosis after orthopedic surgery
is an excellent end point for determining the relative effi-
cacy of antithrombotic agents, since a high rate of events
is observed. However, the clinical significance of these large-
ly asymptomatic thrombi is uncertain. If untreated, how
many will lead to thromboembolic complications?
Before a strategy of extending the duration of prophy-
laxis after joint arthroplasty beyond discharge from the
hospital is developed, possibly increasing the risk of bleed-
ing, we feel that large, randomized, controlled trials are
required to determine whether prolonging prophylaxis re-
duces the rate of clinically important venous thromboem-
bolic complications, such as symptomatic deep-vein throm-
bosis and pulmonary embolism. Venography, because of
its high sensitivity to small deep-vein thrombi, may not be
the appropriate test to diagnose symptomatic deep-vein
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Bergqvist D, Benoni G, Björgell O, et al. Low-molecular-weight heparin 
(enoxaparin) as prophylaxis against venous thromboembolism after total 




 I found the article by Bergqvist et al. to
be a welcome documentation of the prolonged risk of
venous thromboembolism after total hip replacement.
Readers should note some important features of this pa-
per, however. In the study, enoxaparin was given subcuta-
neously once every 24 hours in a 40-mg dose. Current
marketing suggests giving 30 mg every 12 hours; in the
United States, enoxaparin can be purchased only in 30-mg
prefilled syringes.
In addition, the cost of 40 mg of enoxaparin, adminis-
tered subcutaneously each day, would be 300 times that
of daily warfarin sodium, a most acceptable alternative for
prophylaxis against venous thromboembolism in outpa-
tients ($15.00 vs. $0.05 per day). Although monitoring
warfarin sodium would require an occasional measurement
of the prothrombin time, the expense of this would be far
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 In one respect, our study does not differ
from many other studies of thromboprophylaxis — we do
not fully know the clinical relevance of asymptomatic
deep-vein thrombosis. Besides our study, three additional
studies have arrived at similar conclusions — that pro-
longed prophylaxis does significantly reduce the frequency





 Obviously, there is much that is still un-
known: the clinical relevance of late thrombosis for pulmo-
nary embolism and the post-thrombotic syndrome, the re-
producibility of our findings in a routine clinical setting,
economic implications, and detailed definition of risk groups,
among others. An indication that prolonged prophylaxis
may be of benefit is the reduction in the rate of sympto-
matic deep-vein thrombosis in our study from 8 to 2 per-




 from 8 to 3 percent.
However, in our paper we did not recommend the wide-
spread use of prolonged prophylaxis until more infor-
mation is obtained. In the past, most studies of thrombo-
prophylaxis focused on clinical end points, then attention
switched to “objective” diagnostic methods such as ve-
nography and the fibrinogen-uptake test, and now we have
returned to studying clinical end points.
I have no comments regarding the dosage question
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 We view with concern the claim of Geerts




 that the potent anticoagulant low-
molecular-weight heparin can safely be used as routine
prophylaxis against deep venous thrombosis in trauma vic-
tims. The study compared low-dose heparin with low-
molecular-weight heparin in a cohort of 265 patients. The
authors found that deep venous thrombosis occurred at a
higher rate in the low-dose–heparin group (60 of 136 pa-
tients, or 44 percent) than in the low-molecular-weight–









minus 31 percent of 136) cases of deep venous
thrombosis may have been prevented in the group that re-
ceived low-molecular-weight heparin. This reduction in
the rate of deep venous thrombosis was purchased, how-
ever, at the price of five episodes of severe hemorrhage in
the low-molecular-weight–heparin group, including one sub-
dural hematoma requiring operative drainage. Geerts et al.
note that only one episode of bleeding (a nosebleed) oc-
curred in the low-dose–heparin “control” group but claim
that there was no difference between the two groups on
the basis of a Fisher’s exact test P value of 0.12.
The real concern in patient care is not deep venous
thrombosis but pulmonary embolism. Ironically, the sin-
gle pulmonary embolism that occurred in this study was
in a member of the low-molecular-weight–heparin group.
Other therapies have been proposed to deal with potential
pulmonary embolism that do not pose the risk of antico-
agulation. The Greenfield vena caval filter has been suc-
cessfully employed in several prospective studies with min-






Thus, the authors have misunderstood the risks that
trauma patients face. Deep venous thrombosis is usually
asymptomatic and rarely fatal. Hemorrhage is the constant
and paramount risk. Anticoagulation therapy for such pa-
tients has led to complications in these authors’ hands.
Overall, 18 probably asymptomatic deep venous thrombo-
ses were prevented by a therapy that caused five clinically
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 Unfortunately, Osler and Rogers miscon-
strue both the objectives of our study and its results. We
designed an efficacy trial using total deep-vein thrombosis,
detected by contrast venography, as the primary outcome.
While we clearly demonstrated the superior efficacy of the
low-molecular-weight heparin enoxaparin over low-dose
heparin in reducing the total rate of deep-vein thrombosis,
we also emphasized enoxaparin’s 58 percent reduction in
the risk of proximal deep-vein thrombosis — an outcome
of greater clinical importance. Eventually, we hope that in-
vestigators will demonstrate in effectiveness studies that
thromboprophylaxis decreases the rate of clinically impor-
tant thromboembolic events. However, our important first
step involved performing a double-blind, randomized trial
with a sensitive and objective measure of outcome.
Despite the early use of anticoagulant prophylaxis, bleed-
ing was uncommon (occurring in less than 2 percent of
patients). We described the six bleeding episodes so that
readers could make their own decision about which were
clinically relevant. “Severe hemorrhage” occurred in only
one patient, and there were no significant differences be-
tween the bleeding studies in the two groups. The observed
bleeding rate, according to the same definition, was also
equivalent to that in studies of elective arthroplasty. This










it provides strong reassurance that anticoagulant prophy-
laxis can be safely used in patients with major trauma.
We do not misunderstand the risks that trauma patients
face. On the contrary, the two primary authors have per-
sonally seen and followed until discharge every trauma pa-
tient at our center for more than five years. Although we
and our surgical colleagues share the concern about the
potential for bleeding in these patients, we have been im-
pressed with the absence of clinical bleeding associated
with an aggressive prophylaxis regimen based primarily on
the use of enoxaparin. To date, we have not encountered
serious bleeding complications in these patients that could
be attributed to the prophylaxis.
Finally, there is not a single published trial in which
trauma patients were randomized to the use of a vena caval
filter. We agree that the use of filters may well be associat-
ed with fewer pulmonary emboli as compared with no
prophylaxis or ineffective prophylaxis. The important as
yet unresolved issue, however, is the benefit and cost effec-
tiveness of filters when added to a prophylaxis regimen
proved to be efficacious. In the meantime, it is imprudent
to recommend the use of an invasive, permanent, and very
costly device that is associated with both short-term and
long-term complications and that increases the incidence
of deep-vein thrombosis until evidence from at least one
methodologically sound trial demonstrates that the use of
filters is necessary or cost effective. 
Our data provide strong evidence that low-molecular-
weight heparin is an effective, safe method of prophylaxis
in this extremely high risk group of patients. We encourage
physicians interested in the care of trauma patients to ad-
vocate evidence-based thromboprophylaxis strongly and
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Association between Prior Cytomegalovirus 





 The association between seropositivity for
cytomegalovirus (CMV) and restenosis after coronary





intriguing, but their analysis leaves open several questions.
The authors included four patients in the CMV-positive
group who, though initially seropositive, were seronega-
tive at the six-month follow-up visit. Three of these pa-
tients had initial CMV titers just above the cutoff for ser-
opositivity, whereas one had a midrange titer; all the titers
dropped to nearly zero on follow-up. This raises the ques-





 Since they all had restenosis, including them in the
CMV-positive category has substantial bearing on the re-
sults. Had the infections been classified on the basis of the
results of serologic testing at six months rather than be-
fore atherectomy, our calculations suggest that CMV would
not have been identified as a risk factor for restenosis
(odds ratio, 2.4; 95 percent confidence interval, 0.7 to
8.3). Given the uncertainty of these patients’ CMV status,
it would seem prudent at a minimum to omit them from
the analysis.
Another problem we perceived is the use of the CMV
titer as a continuous variable. Although it would be inter-
esting to correlate titers with outcomes, only patients con-
sidered to be seropositive should be studied. Seronegativ-
ity is used to indicate the absence of prior exposure to
CMV; therefore, no variation in a negative titer is mean-
ingful. Moreover, since the distribution of titers was mark-
edly skewed, some method of normalizing the data must
be used before the parametric methods described can be
employed. As presented, the use of continuous titers gives
no more information than the dichotomous analysis. 
Finally, we have reservations about the analyses that
were conducted “by vessel” rather than “by patient.” The
coronary vessels of an individual patient are not independ-
ent of one another. Not only might events in one part of
the heart influence events elsewhere, but the inclusion of
more than one vessel from a given patient may give undue
weight to unrecognized confounding factors. Other stud-
ies have shown that coronary arteries differ in their risk of
restenosis, and patients with multivessel disease may also




 A more complete description of the
vessels studied, including an indication of whether the pa-
tient had multivessel disease, would make it easier to un-












Stanford University School of Medicine
Stanford, CA 94305
1. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cy-
tomegalovirus infection and the risk of restenosis after coronary atherecto-
my. N Engl J Med 1996;335:624-30.
2. Landini MP, Mach M. Searching for antibodies specific for human cy-
tomegalovirus: is it diagnostically useful? When and how. Scand J Infect 
Dis Suppl 1995;99:18-23.
3. Fishman RF, Kuntz RE, Carrozza JP Jr, et al. Long-term results of di-
rectional coronary atherectomy: predictors of restenosis. J Am Coll Cardiol 
1992;20:1101-10.
4. Giuliani ER, Gersch BJ, McGoon MD, Hayes DL, Schaff HV, eds. 
Mayo Clinic practice of cardiology. 3rd ed. St. Louis: Mosby–Year Book, 
1996.
To the Editor: Zhou and colleagues report that prior
CMV infection, as assessed by titers of anti-CMV IgG an-
tibodies, is an independent risk factor for the development
of restenosis six months after directional coronary atherec-
tomy. The authors observed a 43 percent rate of restenosis
in the seropositive patients, as compared with an 8 percent
rate in the seronegative patients. These findings would ap-
pear to strengthen the earlier demonstration by the same
group1 of CMV DNA sequences in atherectomy samples
with restenosis and the production of IE84, one of the vi-
rus’s immediate early proteins, by smooth-muscle cells
grown in vitro from such lesions. 
Since titers of anti-CMV IgG antibodies did not change
during the study period, the authors affirm that their re-
sults “are most compatible with the idea that either the vi-
rus produced an abortive infection . . . or viral replica-
tion occurred locally in the absence of systemic viremia.”2
It is conceivable, therefore, that the local detection of
588  Februar y 20, 1997
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CMV messenger RNA (mRNA) would be needed to prove
definitively that active CMV infection has a pathogenetic
role in the development of restenosis and ischemic syn-
dromes. In this respect, we recently reported3 that of a
group of atherectomy specimens from 40 patients with
stable or unstable angina, none of the 33 patients with pri-
mary lesions, and not even the 7 with restenosis, were pos-
itive for CMV IE84 mRNA. Although the small samples
did not allow us to study the presence of both DNA and
RNA or measure anti-CMV IgG antibodies in our pa-
tients, our findings suggest that the authors’ hypothesis,
that an active local CMV infection may have a pathogenet-




Catholic University of the Sacred Heart
Rome 00168, Italy
1. Speir E, Modali R, Huang E-S, et al. Potential role of human cytomeg-
alovirus and p53 interaction in coronary restenosis. Science 1994;265:391-
4.
2. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cy-
tomegalovirus infection and the risk of restenosis after coronary atherecto-
my. N Engl J Med 1996;335:624-30.
3. Kol A, Sperti G, Shani J, et al. Cytomegalovirus replication is not a 
cause of instability in unstable angina. Circulation 1995;91:1910-3.
The authors reply:
To the Editor: Dr. Kol and associates are correct. Our
data do not allow us to conclude that if CMV contributes
to restenosis, it necessarily operates through a local effect
of the virus on the vessel wall. However, their data clearly
do not prove the converse, for several reasons. First, they
studied only seven patients with restenosis, too few to per-
mit definitive conclusions. Second, the virus may have ex-
pressed CMV mRNA at the time of angioplasty but not
several months later, when the tissue was retrieved for
analysis. Finally, atherectomy retrieves only part of the le-
sion, and therefore there may be false negative results. We
believe that anti-CMV antibodies are a more sensitive
measure of the presence of CMV than atherectomy-based
sampling of lesions.
Drs. Smith and Parsonnet believe that either the four
patients who were seropositive at entry into the study but
seronegative at the six-month follow-up should be exclud-
ed from the analysis or the cohort should be analyzed on
the basis of serologic tests at six months. Excluding the
four patients is unwarranted, because the prospectively de-
termined end point of the study was the correlation be-
tween restenosis and the base-line CMV-antibody status.
Therefore, the analysis was performed without bias due to
knowledge of the restenosis status. To arbitrarily omit four
patients from the analysis because of an end point that was
not identified prospectively would not be scientifically val-
id. Furthermore, if CMV does contribute to restenosis, we
would expect that CMV status at the time of atherectomy
would be most relevant to any CMV-induced effect on re-
stenosis.
We analyzed the CMV titer as a continuous variable in
order to deal directly with the previous point Smith and
Parsonnet raise. Although we defined seropositivity pro-
spectively, any such definition is admittedly arbitrary. We
therefore wanted to ascertain whether there was a corre-
lation between the CMV titer as a continuous variable
and restenosis. This was in fact the case. It would have
been inappropriate to focus only on the seropositive pa-
tients. 
Smith and Parsonnet question our analyses conducted
“by vessel” rather than “by patient.” It is difficult to de-
termine which approach is better. As a result, we analyzed
our data both ways. Thus, 43 percent of patients who were
CMV-seropositive had restenosis, as compared with 8 per-
cent of patients who were seronegative. In addition, the
analyses by vessel, a type of assessment commonly used by
interventional cardiologists, showed that there was a sig-
nificant correlation between the loss index and seroposi-
tivity. The point is moot, however, because of the 75 pa-
tients studied, only 10 had two-vessel angioplasty; the rest
had angioplasty of a single vessel.
We would emphasize that although our article shows a
strong association between prior CMV infection (as indi-
cated by CMV seropositivity) and restenosis, our findings
must be confirmed by further studies before a definite re-
lation between CMV and restenosis can be accepted as
proved.
YI FU ZHOU, M.D.
MYRON A. WACLAWIW, PH.D.
STEPHEN E. EPSTEIN, M.D.
National Heart, Lung, and Blood Institute
Bethesda, MD 20892-1650
Heparin-Induced Skin Necrosis
To the Editor: In the September 5 Image in Clinical
Medicine1 the appearance of the skin lesion described as
heparin-induced skin necrosis is also compatible with a di-
agnosis of ecthyma gangrenosum. The authors do not state
whether the heparin injected was sterile or whether cul-
tures of aspirates from the skin lesion grew gram-negative
organisms. This information would be useful for the dif-
ferential diagnosis.
RICHARD V. MCCLOSKEY, M.D.
Centocor
Malvern, PA 19355-1307
1. Christiaens GCML, Nieuwenhuis HK. Heparin-induced skin necrosis. 
N Engl J Med 1996;335:715.
To the Editor: With respect to the image of heparin-
induced skin necrosis, the authors should have considered
other causes, since the initial injections of heparin appar-
ently did not result in similar lesions. The morphology and
clinical course of a cutaneous lesion resulting in ulceration
requiring skin grafting resemble those of ecthyma gan-
grenosum observed in cases of Pseudomonas aeruginosa
septicemia. Was the patient immunosuppressed? Did she
have any associated systemic symptoms or neutropenia?
Did she receive any antibiotic therapy before or after the
appearance of the skin lesion?
CORRESPONDENCE
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Similar lesions are also possible in primary cutaneous
infections with P. aeruginosa (primary P. aeruginosa pyo-
derma), other gram-negative rods such as Escherichia coli,
klebsiella, or even fungi. Did the authors perform Gram’s
staining and culture of the aspirate from the lesion? Sec-
ondary infection from a contaminated needle or some oth-
er source is always a possibility in hospitals. Biopsy of the
lesion might have documented large numbers of bacteria
invading the blood vessels, with few inflammatory cells in
the case of ecthyma gangrenosum.1
Furthermore, the estimations of protein C and protein
S mentioned in the report seem irrelevant, since deficien-
cies of these proteins predispose patients to skin necrosis
after warfarin therapy and not heparin. Warfarin given
alone in those situations causes a further decrease in pro-
tein C or protein S concentrations (since they are depend-
ent on vitamin K), leading to thrombosis of veins and
capillaries supplying blood to the skin and resulting in ex-
tensive necrosis. 
P. DILEEP KUMAR, M.D.
Sur Central Hospital
Sur, PB 259 Code 411, Oman
1. Pollack M. Pseudomonas infections. In: Isselbacher KJ, Martin JB, 
Braunwald E, Fauci AS, Wilson JD, Kasper DL, eds. Harrison’s principles 
of internal medicine. 13th ed. Vol. 1. New York: McGraw-Hill, 1994:665-
71.
To the Editor: Do the authors know for a fact that hep-
arin was given? Could the patient have received a subcuta-
neous injection of a vasoactive, vasoconstrictive agent,
such as epinephrine?
FREDERICK G. SCHECHTER, M.D.
University of California, Irvine
Irvine, CA 92717
To the Editor: The image of heparin-induced skin necro-
sis is a striking and instructive example of this clinical
problem. However, the report would have been made more
complete by the inclusion of skin-biopsy findings on this
bullous lesion for both routine hematoxylin-and-eosin stain-
ing and immunofluorescence microscopy to establish the
diagnosis.
Despite the clear-cut history of recent heparin injections
at the lesion site, the lesion might have had other causes
— bullous erythema multiforme, pemphigus vulgaris, and
bullous impetigo to name just a few. Since a skin graft was
necessary to repair the lesion, a definitive diagnosis is im-
perative. Histologic findings in heparin-induced necrosis
include extensive thrombosis of the dermal and subcuta-
neous vessels, with hemorrhage and focal epidermal necro-
sis but no evidence of vasculitis or an inflammatory infil-
trate.1 
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The authors reply:
To the Editor: We agree with Drs. McCloskey and Kumar
that infectious causes should be considered in the differ-
ential diagnosis of erythematous, necrotic skin lesions af-
ter an injection. In this case there were no indications of
an infection, the patient was otherwise healthy and was
not immunocompromised, and cultures were negative for
pathogens. 
With respect to the comment of Dr. Schechter, we be-
lieve it is very unlikely that the patient was given an injec-
tion of epinephrine instead of heparin. A skin biopsy may
be helpful if one is doubtful about the diagnosis of a hep-
arin-induced skin lesion, but it is usually not necessary.
Heparin-induced skin lesions at injection sites typically
begin five or more days after the initiation of treatment.
The lesions may appear as painful erythematous plaques or
skin necrosis. Heparin-dependent platelet-activating anti-
bodies may be present. This adverse effect is not uncom-
mon; Warkentin1 observed it in six patients over a 30-
month period.
H. KAREL NIEUWENHUIS, M.D., PH.D.
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Heroin Inhalation and Progressive Spongiform 
Leukoencephalopathy
To the Editor: We report two cases of a progressive
spongiform leukoencephalopathy that, to our knowledge,
has not been reported previously in the United States. The
disease occurred after the patients inhaled heated heroin
vapor, a practice known as “chasing the dragon.”
In Patient 1, a 21-year-old woman with a six-month his-
tory of inhaling heroin vapor, progressive bradykinesia,
ataxia, and slurred speech developed over a two-week pe-
riod. She denied using intravenous drugs. On admission
she had abulia. She followed simple, one-step commands,
but there was a long period of latency before she initiated
movements, which were slow and ataxic. She maintained a
decorticate posture at rest, with normal tendon reflexes.
Over the next two weeks she became mute, spastic, nearly
quadriplegic, and unable to stand or sit.
Blood tests revealed traces of heroin, cocaine, and meth-
adone. The results of serologic tests for the human immu-
nodeficiency virus (HIV), routine analyses of serum chem-
istry, hematologic tests, and cerebrospinal fluid studies
were normal. A computed tomographic scan showed dif-
fuse lucency of the cerebellar and cerebral white matter.
T2-weighted magnetic resonance imaging (MRI) showed
diffuse, symmetric areas of hyperintensity in the white mat-
ter of the cerebellum, the posterior cerebrum, the corti-
cospinal tract, and the lemniscal pathway (Fig. 1). A brain
biopsy revealed spongiform degeneration of the white mat-
ter, with relative sparing of subcortical fibers (U fibers).
Patient 2 was a 40-year-old musician with a six-month
history of intranasal use of cocaine and heroin; he had in-
haled heroin vapor daily with Patient 1 for two weeks,
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ending three weeks before admission. During the week be-
fore admission he had difficulty playing the drums and be-
gan bumping into furniture. He had dysarthric, scanning
speech and saccadic-pursuit eye movements with ocular
dysmetria. His arm movements were ataxic, with dysme-
tria, dysdiadochokinesia, and rebound. His gait was broad-
based and ataxic. HIV serologic, hematologic, and cere-
brospinal fluid studies were normal. Cerebral T2-weighted
MRI findings were similar to those in the first patient: dif-
fuse, symmetric areas of white-matter hyperintensity most
prominent in the cerebellum, but also involving the pos-
terior cerebrum, the splenium of the corpus callosum, and
the posterior limbs of the internal capsule. After treatment
with ubiquinone (coenzyme Q; 300 mg four times daily),
Patient 2 had clinical improvement.
Toxic heroin-induced progressive spongiform leukoen-
cephalopathy has a characteristic pattern on MRI (Fig. 1).
An outbreak in the Netherlands in 1982 involved 47 peo-
ple.2 Subsequent cases have been reported elsewhere in
Europe.1,3-5 In all instances, the mode of ingesting heroin
was to heat the powder on aluminum foil and inhale the
vapor.1-5 There have been suspicions about possible con-
tamination of small batches of the drug by an unknown
substance that is activated by heating. The illness has no
known treatment and a mortality rate of 25 percent.1-3,5
“Dragon chasing” is gaining popularity among drug abus-
ers in the United States as a means of ingesting heroin that
averts the risk of exposure to HIV. Unfortunately, the
practice puts users at risk for toxic heroin-induced leuko-
encephalopathy.
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Figure 1. Modified T2-Weighted Spin–Echo MRI Scan of the
Brain in Patient 1.
There are symmetric lesions of high signal intensity in the oc-
cipital white matter, the posterior limb of the internal capsule,
and the splenium of the corpus callosum. These findings are
characteristic of toxic heroin-induced leukoencephalopathy.1 
